Investigator Site- Wilmington — Wilmington, North Carolina

Investigator Site- Wilmington is a clinical research site located in Wilmington, North Carolina, United States 28401.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigator Site- Wilmington has participated in 1 clinical trials.

Therapeutic areas: Systemic Lupus Erythematosus.

Sponsors: Nektar Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wilmington

Browse all research sites in North Carolina · View every site in Wilmington

• New Hanover Regional Hospital
• Betty Cameron Women & Children's Hospital
• PMG Research of Wilmington
• Research Site
• GSK Investigational Site
• Trial Management Associates
• New Hanover Regional Medical Center
• Accellacare
• Novant Health New Hanover Regional Medical Center
• Accellacare-Wilmington
• Novo Nordisk Investigational Site
• Wilmington Dermatology Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site- Wilmington?

Investigator Site- Wilmington has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site- Wilmington conducted?

Investigator Site- Wilmington has 1 clinical trials on record. Their work covers Systemic Lupus Erythematosus.

Is Investigator Site- Wilmington accredited by Crixeo Clinical Trials?

Investigator Site- Wilmington has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site- Wilmington?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.